Introduction: Who Should Undergo Diagnostics and When

If you notice a firm lump or swelling under your skin, especially in your hands, arms, feet, or legs, it is important to seek medical attention. Epithelioid sarcoma often appears as a small, hard mass that may not cause pain at first, which can lead people to ignore it or mistake it for something less serious^[1]. This cancer is particularly tricky because it can be present for months or even years before you notice any symptoms, and by that time, it may have grown deeper into the tissue where it is harder to see^[2].

Young adults between the ages of 20 and 40 are most commonly affected by epithelioid sarcoma, although the disease can occur at any age^[3]. Men are slightly more likely to develop this cancer than women. If you have had radiation therapy for another type of cancer in the past, you may also be at a slightly higher risk^[11]. Because epithelioid sarcoma is so rare and easily confused with other conditions, anyone with a persistent lump or a sore that does not heal should see a doctor as soon as possible.

Sometimes the lump may break through the skin and form an open sore or ulcer, which is a wound that does not close or heal properly^[4]. These ulcers can be painful and may bleed. If you notice any of these signs, do not wait. Early diagnosis can make a significant difference in treatment outcomes and may help prevent the cancer from spreading to other parts of your body.

It is also worth noting that epithelioid sarcoma can sometimes involve nearby nerves, which may cause symptoms that resemble nerve compression problems, such as numbness, tingling, or weakness in the affected limb^[12]. This can further confuse the diagnosis and lead to delays. If you experience any unusual sensations along with a lump, make sure to mention this to your doctor.

Diagnostic Methods: How Doctors Identify Epithelioid Sarcoma

Diagnosing epithelioid sarcoma can be challenging because it often looks like other, more common conditions. For example, a small firm lump under the skin might be mistaken for a cyst, a wart, or even a poorly healing wound^[9]. Because of this, doctors typically start by ruling out the more common problems before considering a rare cancer like epithelioid sarcoma. This process can take time, but it is an important step to ensure the right diagnosis is made.

Physical Examination

The first step in diagnosing epithelioid sarcoma is a thorough physical examination. Your doctor will look at and feel the lump or mass, checking its size, texture, and location. They will also examine your skin for any ulcers or open sores^[11]. A whole-body skin check may be done to look for other lumps and to rule out skin conditions that might appear similar to epithelioid sarcoma. The doctor will ask you questions about when you first noticed the lump, whether it has grown, and if you have experienced any pain or other symptoms.

Imaging Tests

Once your doctor suspects that the lump could be something more serious, they will order imaging tests. These tests take pictures of the inside of your body and help your doctor see the size and exact location of the tumor. Imaging tests are also used to check whether the cancer has spread to other parts of your body, such as nearby lymph nodes, lungs, or bones^[2].

The most commonly used imaging tests for epithelioid sarcoma include:

• Magnetic Resonance Imaging (MRI): An MRI uses powerful magnets and radio waves to create detailed images of the soft tissues in your body. It is particularly useful for finding tumors in the arms, legs, and other soft tissue areas. The MRI can show how deep the tumor goes and whether it is affecting nearby muscles, nerves, or blood vessels^[4]. Sometimes the borders of the tumor may not be clear on the MRI, and it may appear as multiple small spots instead of one large mass^[8].
• Computed Tomography (CT) Scans: A CT scan uses X-rays and a computer to create cross-sectional images of your body. CT scans are often used to check the chest, abdomen, and pelvis to see if the cancer has spread^[4]. A chest CT is particularly important because epithelioid sarcoma commonly spreads to the lungs.
• Positron Emission Tomography (PET) Scan: A PET scan measures the activity of cells in your body and can help identify areas where cancer cells are growing. It is sometimes combined with a CT scan (called a PET-CT) to provide more detailed information about the extent of the disease^[4].
• X-rays: Plain X-rays may be used to look at the bones and check for any signs of the cancer spreading to the bone^[9].

High-resolution ultrasound is another imaging tool that can be very helpful in diagnosing epithelioid sarcoma, especially when the tumor involves a nerve. Ultrasound uses sound waves to create images and can reveal the shape and structure of the tumor^[12]. It is a non-invasive test that can be done quickly and may help doctors plan the next steps in diagnosis and treatment.

Biopsy: The Definitive Diagnostic Test

While imaging tests can show where the tumor is and how large it is, they cannot tell for certain whether the lump is cancerous. The only way to confirm a diagnosis of epithelioid sarcoma is through a biopsy, which involves removing a small sample of the tumor and examining it under a microscope^[3].

There are different ways to perform a biopsy. In many cases, the doctor will use a special needle to take a sample of tissue through the skin. This is called a needle biopsy or core biopsy, and it can often be done in the doctor’s office or clinic with local anesthesia^[9]. Sometimes, if the tumor is in a difficult location or if more tissue is needed, a surgical biopsy may be performed. This involves making a small incision to remove a piece of the tumor^[8].

After the tissue sample is taken, it is sent to a laboratory where a specialist called a pathologist examines it. The pathologist looks at the cells under a microscope and performs special tests to identify the type of cancer. For epithelioid sarcoma, the pathologist will look for specific features, such as a nodular or lobular architecture (meaning the cells are arranged in small clusters) with areas of dead tissue in the center, surrounded by epithelioid cells^[3].

One of the key markers that helps diagnose epithelioid sarcoma is the loss of a protein called INI-1 (also known as SMARCB1). Up to 90% of epithelioid sarcomas show this loss, and testing for it is an important part of the diagnosis^[3][4]. The pathologist may also test for other markers, such as vimentin, cytokeratins, epithelial membrane antigen, and CD34, which are often present in epithelioid sarcoma^[6]. Additionally, epithelioid sarcomas typically stain positive for a marker called CA125^[6].

It is very important that both the doctor who performs the biopsy and the pathologist who examines the tissue are experienced in dealing with rare cancers like epithelioid sarcoma. Because this disease is so uncommon and can look like other conditions under the microscope, an experienced specialist is more likely to make the correct diagnosis^[8].

Ruling Out Other Conditions

Because epithelioid sarcoma can look like many other, more common conditions, doctors must carefully rule out other possibilities. For example, a lump under the skin might be a benign cyst, a lipoma (a fatty lump), or a skin infection. An ulcer that does not heal might be mistaken for a wound or a skin cancer such as squamous cell carcinoma or basal cell carcinoma^[6]. The biopsy and special staining tests help doctors distinguish epithelioid sarcoma from these other conditions.

Staging the Cancer

Once epithelioid sarcoma is diagnosed, the next step is to determine the stage of the cancer. Staging describes how advanced the cancer is and whether it has spread to other parts of the body. Doctors assign a stage number from 1 (I) to 4 (IV), with Stage I being the least advanced and Stage IV being the most advanced^[2].

Staging is based on several factors, including:

• The size of the tumor
• The location of the tumor (for example, whether it is in the hand or closer to the center of the body)
• Whether the tumor has spread to nearby lymph nodes
• Whether the tumor has spread to distant parts of the body, such as the lungs or bones

Doctors may also use terms like localized to describe cancer that is only in one area, or metastatic to describe cancer that has spread to other organs^[4][11]. Localized epithelioid sarcoma is generally easier to treat, while metastatic disease is more challenging and may require more aggressive treatment.

To determine the stage, doctors use the results of the imaging tests (MRI, CT, PET scans) along with the biopsy results. In some cases, your doctor may also want to check nearby lymph nodes to see if the cancer has spread there. This can be done through imaging or sometimes through a biopsy of the lymph nodes themselves^[8].

Diagnostics for Clinical Trial Qualification

Clinical trials are research studies that test new treatments or ways of managing diseases. For patients with epithelioid sarcoma, clinical trials may offer access to new therapies that are not yet widely available. However, to participate in a clinical trial, patients must meet certain criteria, and specific diagnostic tests are often required to determine eligibility.

Standard Tests for Enrollment

When doctors are considering a patient for a clinical trial, they need detailed information about the patient’s cancer and overall health. The diagnostic tests used to qualify patients for clinical trials are similar to the tests used for standard diagnosis and staging, but they may be more detailed or repeated more frequently.

Common tests and criteria for clinical trial enrollment include:

• Confirmed diagnosis: The patient must have a biopsy-confirmed diagnosis of epithelioid sarcoma, with testing for the loss of INI-1 protein or the SMARCB1 gene abnormality^[3][4]. This is important because clinical trials for epithelioid sarcoma may specifically target tumors with this genetic change.
• Imaging scans: Patients will need recent imaging scans (such as MRI, CT, or PET scans) to show the size and location of the tumor and to check for any spread to other parts of the body. These scans provide a baseline that doctors can use to measure whether the treatment is working^[4].
• Blood tests: Blood tests are often required to check the patient’s overall health and to make sure their organs (such as the liver and kidneys) are functioning well enough to handle the treatment^[4]. Blood tests may also measure specific markers related to the cancer or the immune system.
• Stage and grade of the cancer: Clinical trials may have specific requirements about the stage or grade of the cancer. For example, some trials may only accept patients with advanced or metastatic disease, while others may be looking for patients with localized tumors^[2].
• Previous treatments: Some clinical trials are designed for patients who have already tried standard treatments, such as surgery or chemotherapy, while others may accept patients who have not yet been treated. Your doctor will need to know your treatment history to determine which trials you might be eligible for.

Genetic and Molecular Testing

In addition to the standard diagnostic tests, some clinical trials may require more advanced testing of the tumor. This can include genetic testing or molecular testing to look for specific changes in the genes or proteins of the cancer cells. For epithelioid sarcoma, testing for the SMARCB1 gene abnormality is particularly important, as this is the most common genetic change seen in this type of cancer^[6][4].

Some newer treatments, known as targeted therapies, are designed to specifically attack cancer cells that have certain genetic or molecular features. For example, a drug called tazemetostat has been developed to target tumors with the loss of INI-1 function, which is common in epithelioid sarcoma^[9]. To qualify for clinical trials testing these types of drugs, patients will need to have genetic or molecular testing of their tumor to confirm that it has the right features.

Performance Status and Quality of Life Assessments

Clinical trials also often assess the patient’s overall health and ability to carry out daily activities. This is called the performance status and is usually measured using a standard scale. Patients who are able to take care of themselves and carry out most normal activities are more likely to be eligible for clinical trials. Some trials may also include questionnaires or assessments about the patient’s quality of life, symptoms, and how the cancer is affecting their daily life.

Ongoing Monitoring During Trials

Once a patient is enrolled in a clinical trial, they will undergo regular diagnostic tests to monitor how the treatment is working. This typically includes repeat imaging scans (such as MRI or CT scans) at regular intervals to measure changes in the size of the tumor. Blood tests are also done regularly to check for side effects and to monitor the patient’s overall health. The frequency and type of testing will depend on the specific trial and the treatment being studied.